Nucleic acid enzymes for cleaving DNA by Joyce, Gerald F.
I11111 111ll Il1 Il11 III III III 11111 III III 1ll111ll1 
US006194180B3 
(12) United States Patent (io) Patent No.: US 6,194,180 B1 
Joyce (45) Date of Patent: *Feb. 27,2001 
(54) 
(75) 
(73) 
NUCLEIC ACID ENZYMES FOR CLEAVING 
DNA 
Inventor: Gerald F. Joyce, Encinitas, CA (US) 
Assignee: The Scripps Research Institute, La 
Jolla, CA (US) 
Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 0 days. 
This patent is subject to a terminal dis- 
claimer. 
Notice: 
Appl. No.: 08/183,734 
Filed: Jan. 19. 1994 
Related U.S. Application Data 
Continuation of application No. 081007,732, filed on Jan. 22, 
1993, now abandoned, which is a continuation of application 
No. 071464,530, filed on Jan. 12, 1990, now abandoned. 
Int. C1.7 ............................. C07H 21/04; C12Q 1168; 
C12N 15185 
U.S. C1. ........................... 435/91.31; 43516; 4351325; 
4351333; 536123.1; 536123.2; 536124.5 
(58) Field of Search .................................. 536123.1, 23.2, 
536124.5; 43516, 91.31, 325, 333 
(56) References Cited 
U.S. PATENT DOCUMENTS 
4,987,071 111991 Cech et al. ........................ 435171.31 
5,180,818 111993 Cech et al. .......................... 536123.1 
OTHER PUBLICATIONS 
Cech, Science 236: 1532-1539 (1987). 
Burch, Gene 73: 273-294 (1988). 
Sugimoto, et al., Nucl. Acid Res. 17 355-371 (1989). 
Joyce, et al., Nucl. Acid Res. 17 7879-7889 (1989). 
Doudna, et al., Nature 339: 519-522 (1989). 
Primary Examinerqobert  A. Schwartzman 
Assistant E x a m i n e r h d r e w  Wang 
(74) Attorney, Agent, or Fi rmThomas  Fitting; Emily 
Holmes 
(57) ABSTRACT 
The present invention discloses nucleic acid enzymes 
capable of cleaving single-stranded DNA in a site specific 
manner. 
5 Claims, 11 Drawing Sheets 
https://ntrs.nasa.gov/search.jsp?R=20080006982 2019-08-30T03:11:03+00:00Z
U S .  Patent Feb. 27,2001 
FIG. 1A 
G i) 
t 
HO 
Sheet 1 of 11 US 6,194,180 B1 
FIG. 1B 
($ 
+ 
U S .  Patent Feb. 27,2001 Sheet 2 of 11 
FIG. 1C 
+ 
US 6,194,180 B1 
FIG. 1D 
f ENDONUCLEASI 
f 
+st + H O A p  
KINASE 
LIGASE 
PHOSPHATASE f 
U S .  Patent Feb. 27,2001 Sheet 3 of 11 US 6,194,180 B1 
* 3  3--6 
d- 
Q 
0 
0 
* T- 
m e 
rn cu 
4 
L L  
0 
I- 
0-0 a 
0-0 
cc--3 n a--3 Q) 
+ 
(3--0 
E--3 
3 3  
c 3 a  
3 4  
a cv 
cj 
LL 
U S .  Patent Feb. 27,2001 Sheet 4 of 11 US 6,194,180 B1 
FIG. 2B 
L2.1 
5' 
L1 
L2 
U 
' A "  
A 
C 
G 
f l  
U 
P1 
splice 
site 
/-+ 
C 
A 
flu 
u 
A 
C C 
+ G-C 
G-C R-U 
fl-u 6 A-U 
A-U P2 C-Ge 
'u-6 U-G 50 
C-6 A-U 
U-ft U-fl 
C-6 U-G 
U-6 + G-C 
C 
5'- C-6 -A-A-R-R-U-A 
A U U  
G G 
A C 
U-A 
4 A-U 4 
A C  
C-G 
C-G 
R-u 
A-u P2.1 A-U 
I R  
U-R 
U-R 
u-f14 
9 C-G u-c - G-CRR 
TO FIG, 2 A  
U S .  Patent Feb. 27,2001 Sheet 5 of 11 
L5b 
I 5d 
FIG. 2C 
P5b 
4 
A %UUUGAGA-U-G-G-CCU~ 
l l l l l l l l  I I  
GGGRCUCU G 
R 
7-U 
F1 G 
P5c 
i 
C-G 
A-U 
U-RFIU 
I R 
P5a G-CGA 
A-U 4 
C-G 
U I  
4 U-A 
G-C 
C-G 
C-G 
G R  
A C  C 
R A  
R-U 
4 U-G '200 
P 5  G-U 
G-C 
G-C 
US 6,194,180 B1 
G 
R 
0 L5c 
I TO FIG. 2 A  
U S .  Patent Feb. 27,2001 Sheet 6 of 11 US 6,194,180 B1 
.3 
G U  
R n  R 
R R  
G-C 
G-C TO FIG. 3C 
P4 I f3 G-C 
C-G P6 G-C 
5'- GGRGGGRACRRGRCCGUCR A A U U-R 
P3 ucucuc . 3 1 I I l I I  .3 
G C C A  
I 1 1 1 1  I I  I I  A 
CUGGCUGUR p7 $"%G 
G k. 'FIUCRGRCR 
1 1 1 1 1  I 4CG 
G URGRRGGG 
L8 U 111111I 
A uUCUUCUC A U A A G A U R UAGUC-GGA 
I I I  u 
P 8  3'-G-CU c fl 
FIG. 3 A  
U S .  Patent Feb. 27,2001 Sheet 7 of 11 US 6,194,180 B1 
P5b P5c 
L5b 
A 
FIG. 3B 
L1 
U A 
C u 
G A 
A C 
A-U 
A-U 
A-U 
flu * U  
C 
I I  
L2.1 
f l U U  
L2 R-l l  
G G  
A C  
U-fl 
U G  f l c  
C A  
G-C 
G-C 
fl-U 
A-U 
U-A 
U-G 
G-C 
fl u- 
P2 618 
I 
f i .  c 
C-G 
C-G 
A-U 
A-U 
U-A 
U-A 
U-fl 
C-G 
U-G 
-A-G-C 
P2.1 T-uR 
I 
ACUUUG A G FI - U- G - G -CCUU G 
%-U 
I I I I I I I I  I l l  c 
G GGGACUCU G AuGGGRAR 
C-G 
C-G 
A-U 
U-AAU 
I f l  
P5a G-CGfl 
R-U 
C-G 
U I  
G-C 
C-G 
C-G 
U-A ~ P 5 a b c  
I I  
L5c 
d, 
G A  
A A  
fl-U 
C-G 
U-G 
P5 G-U 
G-C 
G-C 
c R c  
I 1  
A P5 
I To 3A 
U S .  Patent Feb. 27,2001 Sheet 8 of 11 US 6,194,180 B1 
FIG. 3C - A P6 ~ P 6 b  
TO FIG. 3 A  pea P6b 
-uccUflfl -UCRRCRG U 
I l l  G 1 1 1 1 1 1 1  C L6b 
- C G U A G G u R U y  --AGUUGUCu u 
-A 
G A P9 
G 
CC-G- C-G -G-R-U U U 
U-A U-G R-U 
C-G R-U C-G 
C-G C-G A-U 
C-G G-C A-U 
G-C U-fl 
A G  U G  u u  
G U  G G 
L9 R G  U-R 
R-U 
U-A 6-C ~ 9 . 1 a  6-U U-A 
G-C C-G 
R R  G R  
U R  R f l  
L9.2 G C  
19 .la 
U I P9 G-C pg.1 P9. 
u u  
U f l R  u R 
A-U P9 
2 
.2a 
U S .  Patent Feb. 27,2001 Sheet 9 of 11 US 6,194,180 B1 
FIG, 
U S .  Patent 
t 
t 
Feb. 27,2001 Sheet 10 of 11 
c j  
ii 
US 6,194,180 B1 
t 
a 
W 
t 
U S .  Patent Feb. 27,2001 Sheet 11 of 11 US 6,194,180 B1 
w*t* 
A P6 
h P2 
FIG. 6 
US 6,194,180 B3 
2 
cleave RNA substrates in a sequence specific manner by 
Zaug et al., Nature, 324:429-433 (1986). 
The structure of Group I introns has been recently 
reviewed by J. Burke, Gene, 73:273-294 (1988). The struc- 
ture is characterized by nine base paired regions, termed 
Pl-P9 as described in Burke et al., Nucleic Acids Res., 
15:7217-7221 (1987). The folded structure of the intron is 
clearly important for the catalytic activity of the Group I 
introns as evidenced by the loss of catalytic activity under 
lo conditions where the intron is denatured. In addition, muta- 
tions that disrupt essential base-paired regions of the Group 
I introns result in a loss of catalytic activity. Burke, Gene, 
73:273-294 (1988). Compensatory mutations or second-site 
mutations that restore base-pairing in these regions also 
restore catalytic activity. Williamson et al., J .  Biol. Chem., 
262:14672-14682 (1987); and Burke, Gene, 73:273-294 
(1988). 
Several different deletions that remove a large nucleotide 
2o segment from the Group I introns (FIG. 2) without destroy- 
ing its ability to cleave RNA have been reported. Burke, 
Gene, 73:273-294 (1988). However, attempts to combine 
large deletions have resulted in both active and inactive 
introns. Joyce et al., Nucleic Acid Res., 17:7879 (1989). 
To date, Group I introns have been shown to cleave 
substrates containing either RNA, or RNA and DNA. Zaug 
et al., Science, 231:470-475 (1986); Sugimoto et al., Nucleic 
Acids Res., 17:355-371 (1989); and Cech, Science, 
236:1532-1539 (1987). ADNAcontaining 5 deoxycytosines 
30 was shown not to be a cleavage substrate for the Tetrahy- 
mena IVS, a Group I intron by Zaug et al., Science, 
231 :470475 (1 986). 
25 
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NUCLEIC ACID ENZYMES FOR CLEAVING 
DNA 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
The present application is a continuation of U.S. appli- 
cation Ser. No. 081007,732, filed Jan. 22, 1993, now 
abandoned, which is a continuation of U.S. application Ser. 
No. 071464,530, filed Jan. 12, 1990, now abandoned, the 
disclosures of which are incorporated by reference herein. 
DESCRIPTION 
This invention was made with government support under 
NASA Grant No. NAGW-1671. The government may have 
certain rights in the invention. 
TECHNICAL FIELD 
The present invention relates to nucleic acid enzymes for 
cleaving DNA. 
BACKGROUND 
Some genes have their coding sequences interrupted by 
stretches of non-coding DNA. These non-coding sequences 
are termed introns. To produce a mature transcript from 
these genes, the primary RNA transcript (precursor RNA) 
must undergo a cleavage-ligation reaction termed RNA 
splicing. This RNA splicing produces the mature transcript 
of the polypeptide coding messenger RNA (mRNA), ribo- 
somal RNA, or transfer RNA (tRNA). Introns are grouped 
into four categories (Groups I, 11,111, and IV) based on their 
structure and the type of splicing reaction they undergo. 
Of particular interest to the present invention are the 
Group I introns. Group I introns undergo an intra-molecular 
RNA splicing reaction leading to cyclization that does not 
require protein cofactors, Cech, Science, 236:1532-1539 
(1987). 
The Group I introns, including the intron isolated from the 
large ribosomal RNA precursor of Tetrahymena 
therrnophila, have been shown to catalyze a sequence- 
specific phosphoester transfer reaction involving RNA sub- 
strates. Zaug and Cech, Science, 229:1060-1064 (1985); 
and Kay and Inoue, Nature, 327:343-346 (1987). This 
sequence-specific phosphoester transfer reaction leads to the 
removal of the Group I intron from the precursor RNA and 
ligation of two exons in a process known as RNA splicing. 
Splicing reaction catalyzed by Group I introns proceeds via 
a two-step transesterification mechanism. The details of this 
reaction have been recently reviewed by Cech, Science, 
236:1532-1539 (1987). 
The splicing reaction of Group I introns is initiated by the 
binding of guanosine or a guanosine nucleotide to a site 
within the Group I intron structure. Attack at the 5' splice site 
by the 3'-hydroxyl group of guanosine results in the covalent 
linkage of guanosine to the 5' end of the intervening intron 
sequence. This reaction generates a new 3'-hydroxyl group 
on the uridine at the 3' terminus of the 5' exon. The 5' exon 
subsequently attacks the 3' splice site, yielding spliced exons 
and the full-length linear form of the Group I intron. 
The linear Group I intron usually cyclizes following 
splicing. Cyclization occurs via a third transesterification 
reaction, involving attack of the 3'-terminal guanosine at an 
interval site near the 5' end of the intron. The Group I introns 
also undergo sequence specific hydrolysis reaction at the 
splice site sequences as described by Inoue et al., J.  Mol. 
Biol., 189:143-165 (1986). This activity has been used to 
BRIEF SUMMARY OF THE INVENTION 
3s 
It has now been discovered that Group I introns have the 
ability to cleave single-stranded DNA substrates in a site 
specific manner. 
Therefore the present invention provides a method of 
40 cleaving single-stranded DNA at the 3'-terminus of a pre- 
determined nucleotide sequence present within single- 
stranded DNA. The single-stranded DNA is treated under 
DNA cleaving conditions with an effective amount of an 
endodeoxyribonuclease of the present invention where the 
45 DNA cleaving conditions include the presence of MgC1, at 
a concentration of at least 20 millimolar. 
The present invention also contemplates a composition 
containing an endodeoxyribonuclease enzyme of the present 
invention, single-stranded DNA and magnesium ion at a 
concentration of greater than 20 millimolar. 
The present invention further contemplates an endodeox- 
yribonuclease enzyme capable of cleaving single-stranded 
DNA at a predetermined nucleotide sequence where the 
ss enzyme has a nucleotide sequence defining a recognition site 
that is contiguous or adjacent to the 5'-terminus of the 
nucleotide sequence, a first spacer region located 3'-terminal 
to the recognition site, a P3[5'] region located 3'-terminal to 
the first spacer region, a second spacer region located 
60 3'-terminal to the P3[5'] region, a first stem loop located 
3'-terminal to the second spacer region, a second stem loop 
located 3'-terminal to the first stem loop, a third spacer 
region located 3'-terminal to the second stem loop, and a 
third stem loop located 3'-terminal to the third spacer region, 
65 the third stem loop comprising a 5' stem portion interrupted 
by a nucleotide sequence defining a P3[3'] region capable of 
hybridizing to the P3[5'] region. 
US 6,194,180 B3 
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BRIEF DESCRIPTION OF THE DRAWINGS 
In the drawings forming a portion of this disclosure: 
In FIGS. 1A-lD, the splicing mechanisms of the four 
major groups of precursor RNAs. Wavy lines indicate 
introns, smooth lines indicate flanking exons. For nuclear 
mRNA splicing, many components assemble with the pre- 
mRNA to form the spliceosome; only two, the U1 and U2 
small nuclear ribonucleoproteins, are shown. Nuclear tRNA 
splicing is described by Greer et al., TIBS 9:139-41(1984). 
In FIGS. 2A-2C, the secondary structure of the 7: thev- 
mophila pre-rRNAintron, with the recognition sequence and 
the core structure that is the most conserved region among 
group I introns shown in bold. The nomenclature used to 
denote various structural features is the standard nomencla- 
ture described in Burke et al., Nucleic Acids Pes.  
15:7217-7221 (1987). The nine conserved pairing regions, 
Pl-P9, and the various loops are shown. The nucleotide 
sequence is numbered beginning at the 5' terminus of the 
molecule. 
The recognition site is located at nucleotide 19 to 27, the 
first spacer region is located at nucleotides 27 to 28 and 94 
to 95, the P3[5'] region is located at nucleotides 96 to 103, 
the second spacer region is located at nucleotides 104 to 106, 
the first stem loop is located at nucleotides 107 to 214, the 
second stem loop is located at nucleotides 215 to 258, the 
third spacer region is located at nucleotides 259 to 261 and 
the third stem loop is located at nucleotides 262 to 314. 
In FIGS. 3A-3C, the various deletions removing portions 
of the 7: thevmophili pre-rRNA intron are shown. The 
nomenclature used is the same nomenclature defined in 
Burke et al., NucleicAcids Research, 15:7217-7221 (1987). 
The nucleotide segments removed in each deletion are 
shown with the greek character delta followed by the 
number of the pairing region removed. Combination of 
deletions are noted as Delta P 219 for example. 
In FIG. 4, trans-splicing activity of the wild-type and AP9 
mutant form of the Tetrahymena ribozyme using the sub- 
s t r a t e  G G C C C U C U . A , U A , U A , ( S l ) ,  
d ( G  G C C C T C U . A ,  TA, T A )  ( S 2 ) ,  o r  
d(GGCCCTCT.A,TA,TA) (S3) are shown. 
In FIG. 5,  selective amplification of the Tetrahymena 
ribozyme (E) based on its ability to react with an oligo- 
nucleotide substrate (S) is shown. Top, the L-21 form of the 
ribozyme binds an oligopyrimidine-containing RNA sub- 
strate by complementary pairing. The 3'-terminal G, of the 
ribozyme attacks the phosphodiester bond following a 
sequence of pyrimidines, resulting in transfer of the 3' 
portion of the substrate to the 3' end of the ribozyme. 
Middle, the product of the RNA-catalyzed reaction offers a 
unique site for hybridization of an oligodeoxynucleotide 
used to initiate cDNA synthesis. Bottom, a primer contain- 
ing the T7 promoter is hybridized to the cDNA, the second 
strand of the promoter is completed, the DNA is transcribed 
to RNA. 
In FIG. 6, selective amplification of an ensemble of 
structural variants of the Tetrahymena ribozyme based on 
their ability to carry out a trans-splicing reaction with a DNA 
substrate. Lanes 1-3, trans-splicing with no substrate, the 
RNA substrate GGCCCUCU.A,UA,UA, and the DNA sub- 
strate d(GGCCCTCT.A,TA,TA). Lanes 4-5, selective 
cDNA synthesis of trans-spliced products. Lanes 6-8, suc- 
cessive rounds of transcription and reverse transcription 
leading to amplification of selected materials. Materials 
were separated by electrophoresis in a 5% polyacrylamide/ 
8M urea gel, an autoradiogram of which is shown. 
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DETAILED DESCRIPTION OF THE 
INVENTION 
A. Enzymes 
An endodeoxyribonuclease of the present invention is 
capable of cleaving a single-stranded DNA substrate. 
Typically, the endodeoxyribonuclease is also capable of 
cleaving a single-stranded RNA substrate or a modified 
DNA substrate containing a uracil at the cleavage site rather 
than a thymine. 
The term ribozyme is used to describe an RNAcontaining 
nucleic acid that is capable of functioning as an enzyme. 
Ribozymes include endoribonucleases and endodeoxyribo- 
nucleases of the present invention. 
An endodeoxyribonuclease of the present invention may 
be RNA, modified RNA, RNA-DNA polymer, a modified 
RNA-DNA polymer, a modified DNA-RNA polymer or a 
modified RNA-modified DNA polymer. RNA contains 
nucleotides containing a ribose sugar and adenine, guanine, 
uracil or cytosine as the base at the 1' position. Modified 
RNA contains nucleotides containing a ribose sugar and 
adenine, thymine, guanine or cytosine and optionally uracil 
as the base. A RNA-DNA polymer contains nucleotides 
containing a ribose sugar and nucleotides containing deox- 
yribose sugar and adenine, thymine and/or uracil, guanine or 
cytosine as the base attached to the 1' carbon of the sugar. A 
modified RNA-DNA polymer is comprised of modified 
RNA, DNA and optionally RNA. Modified DNA contains 
nucleotides containing a deoxyribose sugar and nucleotides 
containing adenine, uracil, guanine, cytosine and possibly 
thymine as the base. A modified DNA-RNA polymer con- 
tains modified DNA, RNA and optionally DNA. A modified 
RNA-modified DNA polymer contains modified RNA- 
modified DNA, and optionally RNA and DNA. 
An endodeoxyribonuclease of the present invention is 
capable of cleaving DNA 3' of a predetermined base 
sequence. In addition, an endodeoxyribonuclease of this 
invention is characterized by a nucleotide sequence defining 
a recognition site that is contiguous or adjacent to the 5' 
terminus of the nucleotide sequence, a first spacer region 
located 3'-terminal to the recognition site, a P3[5'] region 
located 3'-terminal to the first spacer region, a second spacer 
region located 3'-terminal to the P3[5'] region, a first stem 
loop located 3'-terminal to the second spacer region, a 
second stem loop located 3'-terminal to the first stem loop, 
a third spacer region located 3-'terminal to the second stem 
loop, and a third stem loop located 3'-terminal to the third 
spacer region, the third stem loop comprising a 5' stem 
portion defining a P3[3'] region capable of hybridizing to the 
P3[5'] region. 
The recognition site of an endodeoxyribonuclease of the 
present invention contains a sequence of at least 2 to about 
8 bases preferably about 4 to about 7 bases, capable of 
hybridizing to a complementary sequence of bases within 
the substrate nucleic acid giving the endodeoxyribonuclease 
its high sequence specificity. For example, an endodeoxyri- 
bonuclease of the present invention with a recognition site 
base sequence of 5'-GGAGG-3' is able to recognize the base 
sequence 5'-CCCTCT-3' present within the single-stranded 
DNA substrate (see Example 2). This same recognition site 
also allows the endodeoxyribonuclease to cleave modified 
DNAsubstrates with high sequence specificity (see Example 
The exact bases present in the recognition site determine 
the base sequence at which cleavage will take place. Cleav- 
age of the substrate nucleic acid occurs immediately 3' of the 
substrate cleavage sequence, the substrate nucleotide 
2.) 
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sequence that hybridizes to the recognition site. This cleav- 
age leaves a 3' hydroxyl group on the substrate cleavage 
sequence and a 5' phosphate on the nucleotide that was 
originally immediately 3' of the substrate cleavage sequence 
in the original substrate. Cleavage can be redirected to a site 
of choice by changing the bases present in the recognition 
sequence (internal guide sequence). See Murphy et al., Proc. 
Natl. Acad. Sci., USA, 86:9218-9222 (1989). (The disclo- 
sures of all references cited within this document are incor- 
porated by reference.) In addition, any combination of bases 
may be present in the recognition site if a polyamine is 
present. See, for example, Doudna et al., Nature, 
339:519-522 (1989). Typically, the polyamine is either 
spermidine, putrescine or spermine. A spermidine concen- 
tration of about 5 mM was shown to be effective. The 
recognition site may also be provided as a separate nucleic 
acid, an external recognition site not covalently coupled to 
the rest of the endodeoxynuclease. External recognition sites 
have been shown to direct endoribonuclease cleavage at a 
specific base sequence by Doudna et  al., Nature, 
339:519-522 (1989). If an external recognition site is used, 
the endodeoxyribonuclease used with it would not contain a 
recognition site but would comprise a P3[5'] region, a 
second spacer region, a first stem loop, a second stem loop, 
a third spacer region and a third stem loop where the third 
stem loop comprises a 5' stem portion defining a P3[3'] 
region capable of hybridizing to said P3[5'] region. 
Use of an endodeoxyribonuclease of the present invention 
with an external recognition site would allows the target 
sequence to be changed by merely changing the external 
recognition site sequence. Use of a plurality of different 
external recognition sequences with an endodeoxyribonu- 
clease of the present invention allows the substrate nucleic 
acid to be cleaved at each of the different base sequences 
encoded by the external recognition sequences. 
First spacer regions typically contain a sequence of nucle- 
otides about 3 bases to about 7 bases, preferably about 5, 
bases in length. Preferably, the nucleotides making up the 
first spacer have the sequence 5'-NNNNA-3', where N 
represents the presence of any nucleotide at that position. 
More preferably, the first spacer region is defined by the 
sequence 5'-AACAA-3'. 
In other preferred embodiments, the first spacer region is 
comprised of a nucleotide sequence defining two spacer 
stem loops. Preferably, the first spacer stem loop is 25 
nucleotides in length, and the second spacer stem loop is 36 
bases in length. More preferably, the first spacer stem loop 
h a s  t h e  b a s e  s e q u e n c e ,  
5'-AGUUACCAGGCAUGCACCUGGUAGUCA-3', and 
the second spacer stem loop has the base sequence, 
5 ' - G U C U U U A A A C C A A U A G A U U -  
GGAUCGGUUUAAAAGGC-3'. 
A stem loop is a secondary structure formed by a nucle- 
otide sequence that has "folded over on itself'. Astem loop 
comprises a 5' nucleotide sequence portion, designated a 5' 
paring segment (P[5']) that is capable of hybridizing to a 
nucleotide sequence located 3' of the P[5'] and is designated 
the 3' pairing segment (P[3']). In a stem loop, the P[5'] and 
P[3'] are connected by a nucleotide sequence called a loop. 
The P[5'] and P[3'] hybridize and form a nucleic acid duplex. 
The nucleic acid duplex formed by the P[5'] and P[3'] does 
not have to be a perfect duplex and may contain stretches of 
nucleotides that are either unpaired or paired to a sequence 
outside the stem loop. 
In preferred embodiments, the P3[5'] region is an eight 
nucleotide sequence. The eight nucleotides present in the 
6 
P3[5'] region may be any eight nucleotides as long as the 
P3[5'] region is capable of hybridizing with the P3[3'] region 
to form the third pairing segment or P3 shown in FIG. 2. The 
formation of P3 by P3[5'] region and P3[3'] region are 
s required for catalytic activity as has been recently reviewed 
by John Burke, Gene, 73:273-294 (1988). 
More preferably, the P3[5'] has the nucleotide sequence, 
5'-GACCGUCA-3'. However, changes in the P3[5'] region 
nucleotide sequences may be made as long as P3 is still able 
10 to form or if compensating changes in the P3[3'] region 
nucleotide sequence have been made as has been demon- 
s t ra ted by Wil l iamson et  a l . ,  J .  B i o l .  Chem. ,  
262:14672-14682 (1987). 
In preferred embodiments, the second spacer region is 
about three nucleotides in length. Typically, any three nucle- 
otides may make up the second space region as long as the 
ribozyme containing this spacer has the desired catalytic 
activity. 
More preferably, the second spacer region has the nucle- 
2o otide sequence, 5'-AAU-3'. However, this sequence may be 
changed as long as the desired catalytic activity is retained. 
In preferred embodiments, the first stem loop is about 108 
nucleotides in length. More preferred, the first stem loop 
corresponds to nucleotides 107 to 214 of FIG. 2. The ten 
most 5'-terminal nucleotides (nucleotides 107 to 117 of FIG. 
2) and the ten most 3'-terminal nucleotides (nucleotides 204 
to 214 of FIG. 2) of the first stem loop are the most critical 
for known catalytic functions. See, for example, John Burke, 
Gene, 73:273-294 (1988). 
In other preferred embodiments, the first stem loop is 
about 39 nucleotides in length. More preferred, the first stem 
loop corresponds to nucleotides 107 to 126 and nucleotides 
196 to 214 in FIG. 2, where nucleotide 126 is directly linked 
In another preferred embodiment, the first stem loop is 20 
nucleotides in length. More preferred, the first stem loop 
corresponds to nucleotides 107 to 116, and nucleotides 205 
to 214 of FIG. 2, where nucleotide 116 is directly linked to 
In preferred embodiments, the second stem loop is about 
44 nucleotides in length. More preferred, the first stem loop 
corresponds to nucleotides 215 to 258 in FIG. 2. The 5 most 
5'-terminal nucleotides (nucleotides 215 to 219 in FIG. 2) 
45 and the 5 most 3'-terminal nucleotides (nucleotides 254 to 
258 in FIG. 2) of the second stem loop are the most critical 
for known catalytic functions. See for example, John Burke, 
Gene, 73: 273-294 (1988). 
In other preferred embodiments, the second stem loop is 
50 about 25 nucleotides in length. More preferably, the second 
stem loop nucleotide sequence substantially corresponds to 
nucleotides 215 to 227 and nucleotides 247 to 258 in FIG. 
2, where nucleotides 227 and 247 are directly linked. In 
another preferred embodiment, the second stem loop is 
5s about 9 nucleotides in length. More preferably, the second 
stem loop substantially corresponds to nucleotides 215 to 
220 and 256 to 258 in FIG. 2 where nucleotides 220 and 256 
are directly linked. 
In preferred embodiments, the third spacer region is about 
60 3 nucleotides in length. More preferably, the third spacer 
region corresponds to nucleotides 259 to 261 of FIG. 2. 
Some nucleotide changes can be made in the third spacer 
region while still preserving the desired catalytic activity. 
See for example, Williamson et al., J .  Biol. Chem., 
65 262:14672-14682 (1987), where the nucleotide at position 
259 was changed to A and the nucleotide at 261 was changed 
to a C while maintaining splicing activity. The nucleotide at 
25 
30 
35 to nucleotide 196. 
4o nucleotide 205. 
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position 260 (FIG. 2) was changed to either G, A or U while yribonuclease to produce a new endodeoxyribonuclease 
preserving the desired catalytic activity as reported in John containing both mutations. 
Burke, Gene, 73:273-294 (1988). In other preferred embodiments, an endodeoxyribonu- 
In preferred embodiments, the third stem loop is about 51 clease of the present invention may have random or defined 
nucleotides in length. These 51 nucleotides are divided into 5 mutations introduced into it using a variety of methods well 
a 5' stem portion defining a P3[3'] region that is capable of known to those skilled in the art. For example, the method 
hybridizing to the P3[5'] region, a loop and a 3' stem portion. described by Joyce et al., Nucleic Acids Research, 
Preferably, the P3[3'] region is about 8 nucleotides in length. 17:711-712 (1989), involves excision of template (coding) 
However, the length of the P3[3'] may vary to correspond strand of double-stranded DNA, reconstruction of the tem- 
with the length of the P3[5'] region. Preferably, the P3[3'] 10 plate strand with inclusion of mutagenic oligonucleotides, 
region begins about 10 nucleotides from the 5' end of the and subsequent transcription of the partially-mismatched 
third stem loop. template. This allows the introduction of defined or random 
More preferably, the third stem loop is 5 nucleotides in mutations at any position in the molecule by including 
length and those nucleotides substantially correspond to polynucleotides containing known or random nucleotide 
nucleotides 262 to 312 in FIG. 2. Preferably, the P3[3'] 15 sequences at selected positions. Alternatively, mutations 
region is about 8 nucleotides in length and those nucleotides may be introduced into the endodeoxyribonuclease by sub- 
substantially correspond to nucleotides 271 to 278 in FIG. 2. stituting 5% dUTP for n p  in the reverse transcription 
Changes, including deletions, mutations, reversions and reaction. 5-Br dU can pair with dG in the "wobble" position 
insertions, can be made within the third stem loop and the as well as dA in the standard Watson-Crick position, leading 
p3[3'] region and still maintain the desired catalytic activity. 20 to A to G and G to A transitions. Similarly, substituting 5-Br 
See, for example, Burke et al., Cell, 45:167-176 (1986) and UTP for UTP in the forward transcription reaction would 
Williamson et al., J.  Bioi. Chem., 262:14672-14682 (1987), lead to C to U and U to C transitions in the subsequent found 
where nucleotide 266 was changed to G and a compensatory of RNA synthesis. 
mutation changing nucleotide 309 to C was made while B. Methods 
maintaining the desired catalytic activity. Other mutations, 25 The method of the present invention is useful for cleaving 
including changing nucleotide 268 to c and at the same time any single-stranded nucleic acid including single-stranded 
changing nucleotide 307 to C, and changing nucleotide 268 DNA, modified DNA, RNA and modified RNA, The single- 
to 307 to A, stranded nucleic acid must only be single-stranded at or near 
were also shown to maintain the desired catalytic activity. 3o the substrate cleavage sequence so that an enzyme of the 
Other changes in the nucleotide sequence of the third stem present invention can hybridize to the substrate cleavage 
loop are also contemplated by the present invention. Chang- sequence by virtue of its recognition sequence. 
ing nucleotides 301 to C (FIG. 2), 302 to 6, and 303 to c has A single-stranded nucleic acid that will be cleaved by a 
been shown to eliminate transesterification activity, but does method of this invention may be chemically synthesized, 
not eliminate site specific cleavage Or GTP binding by 35 enzymatically produced or isolated from various sources 
Williamson et al.,J. Biol. Chem., 262:14672-14682 (1987). such as phages, viruses or cells, including cells, 
Changes in nucleotides 280 and 282 (FIG. 2) together eukaryotic cells, yeast cells and bacterial cells. Chemically 
with compensatory changes in nucleotides 296 and 298 have synthesized single-stranded nucleic acids are commercially 
been shown to preserve the desired catalytic function as available from many sources including, Research Genetics, 
reported in J. Burke, Gene, 73:273-294 (1988). Mutations 4o Huntsville, Ala. Single-stranded phages such as the M13 
such as these preserve a given secondary structure and these cloning vectors described by Messing et al., Pvoc. Nutl. 
and similar mutations would be expected to maintain the Acad. Sei., USA, 74:3642-3646 (1977), and Yanisch-Perron 
desired catalytic activity. et al., Gene, 33:103-119 (1985). Bacterial cells containing 
Changes in the P3[3'] region, nucleotides 272 and 274 single-stranded phages would also be a ready source of 
(FIG. 2), along with compensatory changes in nucleotides 45 suitable single-stranded DNA. Viruses that are either single- 
100 and 102, were made while maintaining the desired stranded DNA viruses such as the parvoviruses or are 
catalytic activity by Williamson et al., J. Biol. Chem., partially single-stranded DNA viruses such as the hepatitis 
262:14672-14682 (1987) and Inoue et al., Cell, 43:431-437 virus would provide single-stranded DNA that could be 
(1985). Changes similar to those changes made above will cleaved by a method of the present invention. Single- 
maintain the desired catalytic activity as long as the par- stranded RNA cleavable by a method of the present inven- 
ticular secondary structure such as a stem loop, pairing tion could be provided by any of the RNAviruses such as the 
region or spacer is maintained. p icornavi ruses ,  togavi ruses ,  o r thomyxovi ruses ,  
en~o~eoxyri~onuc~ease of the present invention may paramyxoviruses, rhabdoviruses, coronaviruses, arenavi- 
also include additional stem loops located 3'-terminal to the ruses Or retroviruses. 
third stem loop. These additional stem loops may contain 5s The methods of this invention may be used on single- 
any number of stem loops as long as the desired catalytic stranded nucleic acid that are present inside a cell, including 
activity is maintained. Preferably, any additional stem loops eucaryotic, procaryotic, plant, mammalian, yeast or bacterial 
have a nucleotide sequence that substantially corresponds to cell. Under these conditions a method of the present inven- 
nucleotides 316 to 402 of FIG. 2. tion could act as an anti-viral agent or a regulatory of gene 
the present invention may combine one or more of the The method of the present invention cleaves single- 
mutations described above. Typically, these deletions stranded DNA at the 3'-terminus of a predetermined base 
change the length of or alter the nucleotide sequence of a sequence. This predetermined base sequence or substrate 
stem loop, the P3[5'], the P3[3'] region, a spacer region or cleavage sequence may contain from 2 to 8 nucleotides. The 
the recognition sequence. The mutation within one catalyti- 65 method allows cleavage at any nucleotide sequence by 
cally active endodeoxyribonuclease may be combined with altering the nucleotide sequence of the recognition site of the 
the mutation within a second catalytically active endodeox- endodeoxyribonuclease. This allows cleavage of single- 
and at the Same time changing 
In preferred embodiments, an endodeoxyribonuclease of 60 expression. 
US 6,194,180 B1 
9 10 
stranded DNA in the absence of a restriction endonuclease such that the endodeoxyribonuclease is able to remain in an 
site at that position. active conformation. An endodeoxyribonuclease in an active 
sequence produces a single-stranded DNA, containing the single-stranded DNA at a Predetermined nucleotide 
substrate cleavage sequence, with a 3'-terminal hydroxyl 5 sequence. More Preferably, the DNA cleaving conditions are 
group. In addition, the cleavage joins the remainder of the at from about PH 7.0 to about PH 8.0. Most Preferred are 
original single-stranded DNA substrate with the endodeox- DNA cleaving conditions at about PH 7.5. 
yribonuclease enzyme. This cleavage reaction and products Preferably, the DNAcleaving conditions are at from about 
produced from this cleavage reaction are analogous to the 15" C. to about 60" C. More preferably, the DNA cleaving 
cleavage reaction and cleavage products produced by the 10 conditions are from about 300" C. to about 56" C. The 
Tetrahymena ribozyme described by Zaug and Cech, temperature of the DNA cleaving conditions are constrained 
Science, 231:470475 (1986) and reviewed by T. R. Cech, only by the desired cleavage rate and the stability of that 
Annual Rev. of Biochem., 59:(1990). The endodeoxyribonu- particular endodeoxyribonuclease at that particular tempera- 
clease of the present invention may be separated from the ture. Most preferred are DNA cleavage conditions from 
remainder of single-stranded DNA substrate by site-specific 15 about 37" C. to about 50" C. 
hydrolysis at the PhosPhodiester bond following the In other preferred methods the present invention contem- 
3'-terminal guanosine of the endodeoxyribonuclease similar plates DNA cleaving conditions including the presence of a 
to the site-specific cleavage at this position described for the polyamine, Polyamines useful practicing the present inven- 
ribozYme acting on RNA by Inow et al., J.  Mol. Bioi., tion include spermidine, putrescine, spermine and the like. 
189:143-165 (1986). Separation of the endodeoxyribonu- 2o Preferably, the polyamine is spermidine and it is present at 
clease from the substrate allows the endodeoxyribonuclease a concentration of about 1 mM to about 15 mM, More 
to carry out another cleavage reaction. preferably, spermidine is present at a concentration of about 
Single-stranded DNA is treated under DNA cleaving 1 mM to about 10 mM. Most preferred, are DNA cleavage 
conditions with an effective amount of an endodeoxyribo- conditions including the presence of spermidine at a con- 
nuclease of the present invention, where the DNA cleaving 25 centration of about 2 mM to about 5 mM. 
conditions include the presence of MgC1, at a concentration The present invention also contemplates a method of 
of at least 20 millimolar. producing a nucleic acid having a predetermined activity. 
An effective amount of an endodeoxyribonuclease is the Preferably, the desired activity is a catalytic activity. 
amount endodeoxyribonuclease required to cleave a prede- A population of Group I nucleic acids is subjected to 
termined base sequence present within the single-stranded mutagenizing conditions to produce a diverse population of 
DNA. Preferably, the endodeoxyribonuclease is present at a mutant nucleic acids. 
sites of 1 to 20. This ratio may vary depending on the length nucleic acids is made up of at least 2 Group I nucleic acids. 
of treating and efficiency of the Particular endodeoxYrib0- 35 Group I nucleic acids are nucleic acid molecules having at 
nuclease under the Particular DNA cleavage conditions least a nucleic acid sequence defining a recognition site that 
employed. is contiguous or adjacent to the 5'-terminus of the nucleotide 
Treating typically involves admixing, in aqueous solution, sequence, a first spacer region located 3'-terminal to the 
the single-stranded DNA, the enzyme and the MgC1, to form recognition site, a P3[5'] region located 3'-terminal to the 
a DNAcleavage admixture, and then maintaining the admix- 4o first spacer region, a second spacer region located 
ture thus formed under DNA cleaving conditions for a time 3'-terminal to the P3[5'] region, a first stem loop located 
period sufficient for the endodeoxyribonuclease to cleave the 3'-terminal to the second spacer region, a second stem loop 
single-stranded DNA at any of the predetermined nucleotide located 3'-terminal to the first stem loop, a third spacer 
sequences present in the single-stranded DNA. region located 3'-terminal to the second stem loop, and a 
oxyribonuclease to cleave the single-stranded DNA has been the third stem loop comprising a 5' stem Portion defining a 
predetermined. The amount of time is from about 5 minutes P3[3'1 region capable of hybridizing to the P3[5'1 region. 
to about 24 hours and will vary depending upon the con- In preferred embodiments, mutagenizing conditions 
centration of the reactants, and the temperature of the include conditions that introduce either defined or random 
reaction. Usually, this time period is from about 30 minutes nucleotide substitutions within the Group I nucleic acid. 
to about 4 hours such that the endodeoxyribonuclease Examples of typical mutagenizing conditions include con- 
cleaves the single-stranded DNAat any of the predetermined ditions disclosed in other parts of this specification and the 
nucleotide sequences present. methods described by Joyce et al., NAR 17:711-722(1989) 
Preferably, the DNA cleaving conditions include the pres- and Joyce, Gene, 82:83-87(1989). 
ence of MgC1, at a concentration of at least 20 mM. 55 In preferred embodiments, a diverse population of mutant 
Typically, the DNA cleaving conditions include MgC1, at a nucleic acid contains at least 2 nucleic acid molecules that 
concentration of about 20 mM to about 150 mM. The do not have the exact same nucleotide sequence. 
optimal MgC1, concentration to include in the DNA cleav- A nucleic acid having a predetermined activity is selected 
ing conditions can be easily determined by determining the from the diverse population of mutant nucleic acids on the 
amount of single-stranded DNA cleaved at a given MgC1, 60 basis of its ability to perform the predetermined activity. 
concentration. One skilled in the art will understand that the In preferred embodiments, selecting includes any means 
optimal MgC1, concentration may vary depending on the of physically separating the mutant nucleic acids having a 
particular endodeoxyribonuclease employed. predetermined activity from the diverse population of 
Preferably, the DNAcleaving conditions are at from about mutant nucleic acids. Typically, selecting includes separa- 
pH 6.0 to about pH 9.0. One skilled in the art will understand 65 tion by size, the presence of a catalytic activity and hybrid- 
that the method of the present invention will work over a izing the mutant nucleic acid to another nucleic acid that is 
wide pH range so long as the pH used for DNA cleaving is either in solution or attached to a solid matrix. Preferably, 
Cleavage at the 3'-terminus of a predetermined base conformation is easily detected by its ability to cleave 
30 
molar ratio of endodeoxyribonuclease to substrate cleavage In preferred embodiments, the population of Group I 
Preferably, the amount of time necessary for the endode- 45 third stem loop located 3'-terminal to the third spacer region, 
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the predetermined activity is such that the mutant nucleic 
activity having the predetermined activity becomes labelled 
in some fashion by virtue of the activity. For example, the 
predetermined activity may be an endodeoxyribonuclease 
activity whereby the activity of the mutant nucleic acid upon s 
covalently linked to it, The mutant nucleic acid is then 
selected by virtue of the covalent linkage. 
acid having a predetermined activity includes amplification 
of the mutant nucleic acid as described in Joyce, Gene, 
82:83-87(1989). 
EXAMPLES 
The following examples illustrate, but do not limit, the 
1. Preparation of Endodeoxyribonucleases. 
present invention, 
its substrate causes the mutant nucleic acid to become The and mutant ribozymes were produced by 
first isolating the 443 base-pair Eco RI to Hind I11 restriction 
endonuclease fragment from the plasmid PT7-21 described 
by Zaug et al., Biochemistry, 273924 (1988) using the 
lar ~ i ~ l ~ ~ ~ ,  ~ ~ ~ b ~ l  et eds, ~~h~ wiley and sons, N~~ 
york (1987). 
This 443 base-pair fragment contains the T7 promoter 
described by Dunn et al.,J. Mol. Biol., 166:477-535 (1983) 
1~ and residues 22-414 of the Tetrahymena I v s  and residues 
In Other preferred embodiment, a mutant standard methods described in Current protocols in Molecu- 
D. Compositions 
Also by the present invention are 
&ions containing an endodeoxyribonuc~ease nzyme of the 
present invention, single-stranded DNA and magnesium ion 
1-25 Of the 3' Tetrahymena exon described by Been et al., 
47:207-216 (1986). This Eco R1 and Hind II1 fragment 
was inserted into the M13 vector, M13mp18 that is similar at a concentration of greater than 20 millimolar. 
to the vector described by Yanisch-Perron et al., Gene, 
Preferably, the endodeoxYribonuclease is Present at a 2o 33:103-119 (1985), that had been previously cleaved with 
concentration of about 0.05 IUM to about 2 mM. TYPicallY, Eco RI Hind 111, and using standard subcloning procedures 
the endodeoxyribonuclease is present at concentration ration described in Current protocols in ~ ~ l ~ ~ ~ l ~ ~  ~ i ~ l ~ ~ ~ ,  
of endodeoxYribonuclease to single-stranded DNA from Ausubel et al, eds. John Wiley and Sons, New York (1987). 
about 1 to 5 to about 1 to 50. More Preferably, the edode-  The resulting M13T7L-21 DNA construct was transformed 
oxyribonuclease is present in the composition at a concen- 2s into E, coli host cells according to the transformation 
tration of about 0.1 IUM to about 1 PM. Most Preferred, are procedure described in Molecular Cloning: A Laboratory 
compositions containing the endodeoxyribonuclease at a ~ ~ ~ ~ ~ l ,  Maniatis et eds,, co ld  spring Harbor 
concentration of about 0.1 pM to about 0.5 pM. Laboratories, Cold Spring Harbor, N.Y. (1989). Single 
Preferably, single-stranded DNA is present in the com- stranded DNA was then Prepared from the M13T7L-21 
position at a concentration of about 0.5 p~ to about 1000 30 transformed cells according to the procedures described in 
p ~ ,  one in the art will understand that there are Current Protocols in Molecular Biology, Ausubel et al, eds. 
many sources of single-stranded DNA including synthetic John WileY and Sons, New York (1987). The accuracy ofthe 
DNA, phage DNA, denatured double-stranded DNA, viral above construction was confirmed by DNA sequencing 
DNA and cellular. using the klenow fragment of E. coli DNA polymerase I 
35 (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) 
at a concentration Of about 2o mM to about 2oo mM. More Sanger et al., Proc. Natl. Acad. Sci., USA, 74:5463-5467 
preferably, the magnesium ion is present in the composition (1977), 
at a concentration of about 20 mM to about 150 mM. One The wild-type and mutant ribozymes were prepared skilled in the art will understand that the magnesium ion 
40 directly from the single-stranded M13T7L-21 DNA using a concentration is only constrained by the limits of solubility modification of the technique previously described by Joyce of magnesium in aqueous solution and a desire to have the and Inoue, Nucleic Acid Research, 17:711-722 (1989). The endodeoxyribonuclease present in the same composition in technique involves construction of a template strand that an active conformation. optionally includes one or more mutagenic oligodeoxy- 
Also contemplated by the present invention are compo- 45 nucleotides. The resulting partially-mismatched double- 
stranded DNA is transcribed directly using T7 RNA poly- 
present invention, single-stranded DNA, magnesium ion at merase. Briefly, a five fold molar excess of a terminator 
a concentration of greater than 20 millimolar and a polynucleotide and a mutator oligo were admixed with 5 pg 
polyamine. of single-stranded M13T7L-21 DNA and a solution contain- 
spermine. More preferably, the polyamine is spermidine and pH 7.5 with HC1(Tris-HC1), 50 mM NaC1 and mM MgC1z. 
is present at a concentration of about 2 m~ to about 10 m ~ ,  This solution was maintained at 70 degrees centigrade (70" 
C.) for 5 minutes and then steadily cooled to 30" C. over 40 
Also contemplated by the present invention are compo- minutes,  if^^^^ u n i t s ( ~ )  of T4 DNA ligase (u,s, 
sition containing an endodeoxyribonuclease enzyme of the ss Biochemicals, cleveland, ohia) and 7.5 u of T4 DNA 
present invention, single-stranded DNA, magnesium ion at polymerase (u.s. Biochemicals) were admixed to the solu- 
single-stranded DNA molecule ending in a 3'-terminal solution contain a final concentration of 20 mM Tris-HCl at 
hydroxyl, and a third single-stranded DNA molecule having p~ 7.5, 50 m~ NaC1, 5 m~ MgC1,, 2 m~ dithiothreitol 
a guanine nucleotide at its 5'-terminal end. 60 (DTT), 1 mM adenosine triphosphate (ATP) and 0.5 mM 
Also contemplated by the present invention are compo- each of dGTP, dTTP, dATP and dCTP (dNTPs). The result- 
sitions containing an endodeoxyribonuclease enzyme of the ing solution was maintained at 37" C. for 60 minutes to 
present invention, singled-stranded DNA and magnesium complete the synthesis of the mutant strand. The resulting 
magnesium ion is present in the and the dideoxynuc~eotide sequencing method described by 
sitions containing an endodeoxyribonuclease enzyme of the 
Preferably, the polyamine is spermidine, putrescine, or 50 ing 20 mM tris[hYdroxY-methYllaminomethane adjusted to 
a concentration Of greater than 2o a second tion together with sufficient amounts of reagents to make the 
ion at a concentration of greater than 20 millimolar, wherein 
said single-stranded DNA is greater in length than the 6s direct the transcription of mutant RNA. 
recognition site present on the endodeoxyribonuclease 
enzyme. 
DNA was purified by ethanol precipitation and then used to 
Transcription took place either in a 10 pl volume con- 
taining 1 pg of mutant DNA, 2 pCi [a3'P] GTP and 50 U of 
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T7 RNA polymerase that was prepared as previously The RNA substrate 5'-GGCCCUCUA,,-3' was prepared 
described by Davanloo et al., Pvoc. Natl. Acad. Sci., USA, by in vitro transcription using a partially single-stranded 
81:2035-2039 (1984), and purified according to a procedure synthetic DNA template according to the methods described 
originally developed by Butler 8~ Chamberlain, J.  Bio. by Milligan et al., Nucleic Acids Res., 4:2527-2538 (1977). 
them., 2575772-5779 (198212 Or in a 400 iul volume s The template contains both strands of the promoter for T7 
containing 10 Pg of mutant DNA, 40 Pci L3H1UTP and RNA polymerase (positions -17 through +1) followed by 
scription mixture also contained 40 mM Tris-HC1 at pH 7.5, 5,. Run-off transcripts of the form 5,-GGCCCUCUk-3,, 
mM (each) NTPs' and was incubated at 370 " for 90 i o  separated by electrophoresis in a 20% polyacrylamidei8M 
urea gel, eluted from the gel, purified by affinity chroma- 
tography on du Pont Nensorb, and sequenced by partial 
RNase digestion Donis-Keller et al., Nucleic Acids 
Research, 1537834798 (1987). RNA substrates having the 
is sequence 5'-GGCCCUCUA,,-3' were used throughout this 
study. 
The were either purchased from a number 
of commercial sources (i.e., Research Genetics, Huntsville, 
20 City, Calif.) oligonucleotide synthesizer according to the 
2,400 u of T7 RNA polymerase. In either case, the tran- 
l5 mM MgCIZ, lo mM dithiothreitol, mM spermidine, and 
the single-stranded template sequence 3'-CGGGAG-ATl,- 
where n=9-16, were obtained, The resulting products were 
minutes. The T7 RNA polymerase was extracted with phe- 
no1 and the transcription products were purified by ethanol 
precipitation. The mutant RNA was isolated by electro- 
phoresis in a 5% polyacrylamidei8 M urea gel, eluted from 
the gel, and purified by ethanol precipitation and chroma- 
tography on Sephadex G-50. 
The Delta P2 mutant was prepared using the mutagenic 
oligodeoxynucleotide 01 (Table 1 and FIG. 3). The partially- 
randomized Delta P2 mutant was prepared using the 
The Delta P5 mutant was prepared using mutagenic oligo- 
nucleotides 03 or 04 (Table 1 and FIG. 3). The Delta P6 
otide 05 (Table 1 and FIG. 3). The Delta P6b mutant was 
prepared using the mutagenic oligodeoxy-nucleotide 06 The ability of the Delta p9 mutant and wild-type 
(Table 1 and FIG, 3). The Delta p9 mutant was prepared 25 ribozymes to cleave three different substrates was deter- 
using the mutagenic oligodeoxy-nucleotide 07 (Table 1 and mined. The reactions were carried out by admixing 0.02M of 
FIG. 3). the ribozyme, 2.0 pM of either GGCCCUCU.A3UA3UA3 
Wild-type and mutant RNAs other than those containing (sl)  O r  d ( G G C C C T C U . A 3 T A 3 T A )  (s2) O r  
the Delta P9 deletion were defined at their 3' end by the d(GGCCCTCT.A3TA3TA) ( s 3 ) 3  30 m M  N-[2- 
oligodeoxynucleotide 08 (Table 1 and FIG. 3). Mutants 30 hYdroxYethYll-PiPerazine-N'-[3-ProPane-s~lfo~ic acid1 
containing the Delta P9 deletion were defined by the Delta (Epps) at PH 7.52 50 mM MgC1z and The 
p9 mutagenic oligo which directs a transcript that includes resulting solution was maintained at 50" C. for one hour. The 
10 nucleotides of the 3' exon. resulting reaction products were separated by electrophore- 
sis in a 5% polyacrylamidei8 m urea gel. The gel was used 
35 to expose x-ray film to produce an autoradiogram shown in 
FIG. 4. 
The Delta P9 ribozyme cleaves the RNAsubstrate, S1 the 
0 2 )  5'-TTTGACGGTCTNNNNCCCTCCTATAGTGAG-3' modified DNA substrate, S2, and the DNA substrate S3 
4o (FIG. 4). 
03) 5'-TGCGTGGTTACTTTCCCGCAA-3' 3. Selection of Mutant Ribozymes Capable of Cleaving 
DNA. 
Mutant Ribozymes capable of cleaving a DNA substrate 
were selected using the in vitro evolution system described 
45 by G. F. Joyce, Gene, 82:83-87 (1989). This technique 
allows a structural variant of Tetrahymena ribozyme capable 
of catalyzing a specific reaction to be selectively amplified 
from a population of Tetrahymena ribozyme structural vari- 
ants. 
This in vitro evolution technique was used to select a 
The 3' exon sequence was removed by RNA-catalyzed Tetrahymena ribozyme structural variant that cleaves a 
site-specific hydrolysis as has been previously, Inoue et al., polydeoxyribonucleic acid (FIG. 5).  The first step in this 
J .  Mol. Biol., 189:143-165 (1986). Briefly, the RNA was technique is the ribozyme trans-splicing reaction involving 
incubated in the presence of 50 mM CHES at pH 9.0 and 10 the attack by its 3'-terminal guanosine at a phosphodiester 
mM MgC1, at 42" C. for 1 hour. Wild-type and mutant ss bond following a sequence of pyrimidines located within a 
RNAs were isolated by electrophoresis in a 5% RNA substrate previously described by G. F. Joyce, Gene, 
polyacrylamidei8M urea gel, eluted from the gel, and puri- 82:83-87 (1989). The product of the reaction is the 
fied by affinity chromatography on du Pont Nensorb (du ribozyme joined to the substrate sequence that lies down- 
Pont Company, Wilmington, DE). RNAs were sequenced by stream from the target phosphodiester (FIG. 5,  top). Selec- 
primer extension analysis using AMV reverse transcriptase 60 tion occurs when an oligodeoxynucleotide primer is hybrid- 
(Life Technologies, Inc., Gaithersburg, Md.) in the presence ized across the ligation junction and used to initiate 
of dideoxynucleotides, using a modification of the methods synthesis of complementary using reverse transcriptase 
described by Sanger et al., Pvoc. Natl. Acad. Sci., USA, DNA(F1G. 5, bottom). The primer ligation junction does not 
74:5463-5467 (1977), except for those containing the Delta bind to unreacted starting materials compared to 
P9 deletion, which were sequenced from the 3' end by partial 65 reaction products, at or below the limits of detection), and 
RNase digestion, Donis-Keller et al., Nucleic Acids Res., thus leads to selective reverse transcription of reactive 
1537834798 (1987). materials. In order to amplify the selected materials, a 
mutagenic o~igodeoxynuc~eotide 02 (Table 1 and FIG, 3). Ala') Or 'ynthesized an Biosystems (Foster 
manufacture's instructions' 
mutant was prepared using the mutagenic oligodeoxynucle- 2. Of DNA by Endodeoxyribo- 
mM 
TABLE 1 
01) 5'-TTTGACGGTCTTGTTCCCTCCTATAGTGAG-3' 
0 4 )  5'-GGACTTGGCTGCGTGGTTACTTTCCCGCAA-3' 
05) 5'-TTTAGTCTGTGAACTCTTGGC-3 
0 6 )  5'-TCTGTGAACTGCATCCAAGCTTAGGACTTGG-3' 
0 7 )  5'-GGCTACCTTACGAGTACTCCGACTATATCTTAT-3' 
08) 5'-CGAGTACTCCAAAAC-3' 
SO 
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primer containing one strand of a promoter for T7 RNA CGACTCACTATAGGAGGGAAAAGTTATCAGGC) 
polymerase is hybridized to the extreme 3' end of the cDNA, primer, heating the resulting solution to 65" C. for 5 minutes 
the second strand of the promoter is completed using a in the presence of 50 mM Tris-HC1 at pH 7.5 and 5 mM DTT 
DNA-dependent DNA polymerase, and the DNA is tran- and then rapidly cooling the solution to 0" C. The solution 
scribed to RNA as has been previously described by Joyce, s is then made to contain 15 mM MgCl,, 2 mM spermidine, 
G. F. in Molecular Biology of RNA, UCLA Symposia on 100 pM (each) dNTPs, 2 mM (each) NTPs 1 U/pL AMV 
Molecular and Cellular Biology, ed., Cech, T. R., reverse transcriptase, 0.2 U/pL DNApolymerase I (Klenow 
94:361-371, Alan R. Liss, New York, (1989) and Kwoh et fragment) and 20 U/pL of T7 RNApolymerase. The solution 
al., Proc. Natl. Acad. Sci., USA, 86, 1173-1177 (1989). was maintained at 37" C. for 1 hour to allow RNA to be 
ne selected material is amplified at the transcription i o  transcribed from the cDNA. This step results in a large 
level due to the high turnover of ~7 RNA polymerase that amplification of the ribozymes having the desired catalytic 
has been previously described by Chamberlin et al., in The activity (FIG. 6, Lane 6, ' L o  of the material). 
Enzymes, ed. P. Boyer, pp. 87-108, Academic Press, New A second round of cDNA synthesis was performed using 
York (1982). Mutations can be introduced by replacing a a n  e q u a l  m o l a r  m i x t u r e  of  t h e  p r i m e r s  
portion of the cDNA with one or more mutagenic oligode- 15 d(CGAGTACTCCAAAC) and d(CGAGTACTCCGAC) to 
oxynucleotides and transcribing the partially-mismatched restore the 3' end of the RNA. The remainder of the cDNA 
template directly as has been previously described by Joyce synthesis was performed as above. The resulting reaction 
et al., Nucleic Acid Research, 17:711-722 (1989). products were analyzed by electrophoresis (FIG. 6, Lane 7). 
Ribozymes produced in this way can also be internally A second round of RNA synthesis was performed using 
labelled with 32P-GTP. 2o the remaining reaction mixture using the RNA synthesis 
conditions described above. Aportion representing l/so of the 
of the Tetrahymena ribozyme to cleave the RNA substrate resulting reaction products were analyzed by gel electro- 
GGCCCUCUAAAUAAAUA (Sl), the modified DNA sub- phoresis and are shown in FIG. 6, Lane 8. 
strate d(GGCCCTCUAAATAAATA) (S2), and the DNA This system allowed the selection of a ribozyme having a 
substrate d(GGCCCTCTAAATAAATA) (S3) was deter- 2s desired catalytic activity from a mixture of ribozymes. 
mined. Briefly, 1 pM each of internally labelled wild-type, The foregoing specification, including the specific 
Delta p6, Delta p2, Delta p9, Delta p 6 p 9  and Delta P2P9 embodiments and examples, is intended to be illustrative of 
ribozymes were admixed with 2 pM of either the S3 DNA the present invention and is not to be taken as limiting, 
substrate Or the s1 RNA substrate, 30 mM EPPS at PH 7-53 3o Numerous other variations and modifications can be effected 
50 mM MgC1z and 2 mM spermidine were admixed to form without departing from the true spirit and scope of the 
endodeoxyribonuclease reaction admixtures. The endodeox- present invention, 
yribonuclease reaction admixture was maintained at 50" C. I claim: 
for one hour. The cleavage of substrate by each of these 1. A method for specifically cleaving a single-stranded 
ribozymes is detected as the appearance of a slower migrat- 3s DNA molecule, comprising the steps of: 
ing ribozyme caused by the ligation of the cleaved substrate (a) providing a first RNAmolecule that is a group I intron 
to the ribozyme (FIG. 6, Lanes 2 and 3). that cleaves a second RNA molecule to leave a 3'-OH, 
Focusing on the DNA substrate S3, two rounds of selec- said first RNA molecule having a deoxyribonuclease 
tive amplification were performed to recover the nucleic activity; and 
acid enzymes, in this case endodeoxyribonucleases, capable 4o (b) contacting said first RNA molecule with said single- 
of cleaving DNA from a collection of ribozyme structural stranded DNA molecule under conditions which allow 
variants including, wild-type, Delta P6, Delta P2, Delta P9, said first RNA molecule to cause said single-stranded 
Delta P6/P6, and Delta P2/P9. These structural variants (1 DNA molecule to be cleaved, said conditions including 
pM, internally labelled with 1 pCi/nmole 32P-GTP) were providing Mg2+ ions and guanosine or guanosine triph- 
admixed with 2 PM DNAsubstrate s3230 mM EPPS at PH 45 osphate at a pH between about 6.0 and about 9.0 and a 
7.5,50 mM MgC1, and 2 mM spermidine and maintained at temperature between about 15" C. and about 60" C. 
50" c .  for 1 hour. The first round of CDNA synthesis was 2. The method of claim 1, further comprising providing 
carr ied out  by admixing  a 20- fo ld  excess  o f  said RNA molecule in a reaction medium at a concentration 
d(TAT3AT3CGAGT) primer, heating the solution to 65" C. sufficient to cause cleavage of at least 1% of a population of 
for 5 minutes in the presence of 50 mM Tris-HC1 at pH 7.5 so the DNA mo~ecu~es in an hour, 
and 5 mM DTT and then rapidly cooling the solution to 0" 3. The method of claim 1, further comprising providing 
c .  The solution was then made to contain 6 mM MgClz, 100 said RNA molecule in a reaction medium at a concentration 
(each) dNTPs and 1 U W  of AMV reverse transcriptase. sufficient to cause cleavage of at least 10% of a population 
The resulting solution was maintained at 37" C. for 20 of the DNA mo~ecu~es in an hour, 
minutes. A small aliquot of the solution was removed and ss 4, The method of claim 1, wherein said RNA molecule 
analyzed by electroPhoresis in a 5% PolYacrYlamide comprises the portions of an RNAmolecule of Tetrahymena 
urea gel. After the first cDNA synthesis, the selected reverse having said deoxyribonuc~ease activity, 
transcriptant of the Delta P6, Delta P2, Delta P9, and Delta 5 .  The method of claim 1, wherein said RNA molecule 
P2/9 ribozymes can be seen in Lane 5 of FIG. 6. comprises a binding site for single-stranded DNA, which 
The RNA is destroyed by alkaline hydrolysis and the 6o binding site is complementary to nucleotides adjacent to a 
monomers removed by ethanol precipitation. RNA was cleavage site on said single-stranded DNA molecule. 
transcribed from the cDNA by admixing a 20-fold excess of 
The ability of a population ofwild-type and mutant forms 
d ( A T  C G A T A A T A  * * * * *  
